NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 49 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,605,000 | -2.9% | 364,800 | +1.2% | 0.23% | -0.4% |
| Q4 2020 | $10,921,000 | +90.4% | 360,500 | +0.0% | 0.23% | +58.9% |
| Q3 2020 | $5,735,000 | -18.7% | 360,454 | +0.9% | 0.15% | -24.7% |
| Q2 2020 | $7,055,000 | +63.0% | 357,409 | +1.8% | 0.19% | +8.4% |
| Q1 2020 | $4,329,000 | -33.3% | 351,100 | 0.0% | 0.18% | -12.7% |
| Q4 2019 | $6,492,000 | +33.5% | 351,100 | 0.0% | 0.20% | +5.7% |
| Q3 2019 | $4,863,000 | -5.4% | 351,100 | 0.0% | 0.19% | +4.3% |
| Q2 2019 | $5,140,000 | – | 351,100 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $19,406,306 | 12.88% |
| StepStone Group LP | 1,573,357 | $1,683,492 | 0.38% |
| EcoR1 Capital, LLC | 6,435,518 | $6,886,004 | 0.23% |
| Euclidean Capital LLC | 1,984,336 | $2,123,240 | 0.23% |
| Boxer Capital, LLC | 500,000 | $535,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 213,676 | $229 | 0.02% |
| Jasper Ridge Partners, L.P. | 303,492 | $324,736 | 0.02% |
| Carson Advisory Inc. | 15,850 | $16,960 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 51,176 | $54,758 | 0.01% |
| Parkwood LLC | 68,314 | $73 | 0.01% |